ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and healthcare industries by providing innovative products and business models. The company comprises several subsidiaries such as ACROBiosystems,bioSeedin,Condense Capital, and ACRODiagnostics.
Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and their clinical applications, and contributes to global health.
Accelerating biologics discovery and development to market and supporting enhanced clinical applications.
Being a cornerstone of the global biopharmaceutical and healthcare industry by providing products, solutions, and business models innovation.
Quality is our strategic commitment. We build an industry innovation platform and keep delivering innovative products, services, and mid-to-long-term innovation strategy. Better experience is our enduring promise of considerate service.
We have established numerous long-term and stable partnerships with the world's top pharmaceutical enterprises and well-known academic institutes.
Pharma
Biotech
Vaccine
Diagnostics
CRO/CDMO
Academia
Our main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.